1.Schwannoma of the Scrotum: Case Report and Review of the Literature.
Mohammad SHAHID ; Syed Shamshad AHMAD ; Shaista M VASENWALA ; Aysha MUBEEN ; Sufian ZAHEER ; Mohammed Azfar SIDDIQUI
Korean Journal of Urology 2014;55(3):219-221
Schwannomas are benign nerve sheath tumors composed of Schwann cells, which normally produce the insulating myelin sheath covering the peripheral nerves. Common locations include the head, neck, mediastinum, and retroperitoneum. These tumors are usually asymptomatic until they become large and compress the surrounding tissues. Most schwannomas occur during the third and fourth decades of life, with an equal gender distribution. We present the case of a schwannoma that originated in the scrotum.
Head
;
Mediastinum
;
Myelin Sheath
;
Neck
;
Nerve Sheath Neoplasms
;
Neurilemmoma*
;
Peripheral Nerves
;
Schwann Cells
;
Scrotum*
2.Quality of life in patients treated for COVID-19–associated mucormycosis at a tertiary care hospital
Pragya KUMAR ; Rajath Rao UR ; Nilanjan ROY ; Deepika AGRAWAL ; Shamshad AHMAD ; Kranti BHAVANA
Osong Public Health and Research Perspectives 2023;14(2):119-128
Objectives:
Coronavirus disease 2019 (COVID-19)–associated mucormycosis (CAM) has emerged as a formidable infection in patients with COVID-19. The aggressive management ofCAM affects quality of life (QOL); thus, this study was designed to assess the QOL in patients with CAM at a tertiary healthcare institution.
Methods:
This cross-sectional study of 57 patients with CAM was conducted over 6 monthsusing a semi-structured standard questionnaire (the abbreviated World Health Organization Quality of Life questionnaire [WHO-BREF]) and a self-rated improvement (SRI) scale ranging from 0 to 9. Cut-off values of ≤52 and < 7 were considered to indicate poor QOL and poor improvement, respectively. The correlations of QOL and SRI scores were evaluated using Spearman rho values.
Results:
In total, 27 patients (47.4%; 95% confidence interval [CI], 34.9%–60.1%) and 26 patients (45.6%; 95% CI, 33.4%–58.4%) had poor QOL and poor SRI scores, respectively. The overall median (interquartile range) QOL score was 52 (41–63). Headache (adjusted B, −12.3), localized facial puffiness (adjusted B , −16.4), facial discoloration (adjusted B, −23.4), loosening of teeth (adjusted B, −18.7), and facial palsy (adjusted B, −38.5) wer e significantly associated with the QOL score in patients with CAM.
Conclusion
Approximately 1 in 2 patients with CAM had poor QOL and poor improvement.Various CAM symptoms were associated with QOL in these patients. Early recognition is the key to optimal treatment, improved outcomes, and improved QOL in patients with CAM.